Dr. Andrew Ching-Hung Chang is the Head of the Section of Thoracic Surgery at Michigan Medicine and the Rogel Cancer Center at the University of Michigan in Ann Arbor. His specialties include adult general thoracic surgery, minimally invasive thoracic surgery, thoracic surgical oncology, and cardiopulmonary transplantation. He is highly skilled in minimally invasive surgery and interventional endoscopy.
The Section of Thoracic Surgery that Dr. Chang heads is known for its innovation in the surgical treatment of diseases of the chest. As a thoracic surgeon, Dr. Change works in tandem with anesthesiologists and other oncologists, as well as pulmonary medicine experts to identify the best outcomes for patients diagnosed with esophageal cancer, lung cancer, and malignant mesothelioma. He is skilled in the use of the da Vinci platform, which shortens patient recovery time and minimizes pain. The University of Michigan’s thoracic surgery department boasts one of the country’s most robust thoracic robotic surgery programs.
Education and Career
Dr. Chang earned his undergraduate degree from the Massachusetts Institute of Technology and then moved on to Johns Hopkins University to pursue his medical education. After earning his medical degree, he completed a General Surgery internship and residency at Vanderbilt University, simultaneously obtaining an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation with renowned thoracic surgeon Dr. Richard N. Pierson, III. Following both of these, he pursued a residency and subsequent fellowship in Thoracic Surgery at the University of Michigan.
After completing his education, Dr. Chang remained at the University of Michigan. Today, in addition to being Head of the Section of Thoracic Surgery, he is the John Alexander Distinguished Professor at the University of Michigan. He is a prolific author and presenter and has published and co-authored many published studies and journal articles.
American Association for Thoracic Surgery
American College of Chest Physicians
American College of Surgeons
American College of Surgeons Oncology Group
Association for Academic Surgery
Esophageal Surgery Club
General Thoracic Surgical Club
Society of Thoracic Surgeons
Society of University Surgeons
Dr. Chang is actively involved in research involving all aspects of thoracic oncology, particularly patient-related outcomes following surgery and tumorigenesis of esophageal cancers. He is currently collaborating with another researcher on the latter. He is also an active member of the Thoracic Surgery Cancer Biology Lab, which focuses on characterizing the molecular and biologic alterations leading to thoracic malignancies with the goal of developing more effective interventions and providing better patient outcomes.